Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7545745 | 0.93 | USP2 (0.44) | KDM4EUSP2THRBPTPN1CYP3A4 | |
| SCHEMBL6322502 | 0.92 | KDM4E (0.36) | KDM4EUSP2THRBPTPN1CYP1A2 | |
| SCHEMBL1783854 | 0.91 | USP2 (0.47) | KDM4EUSP2THRBPTPN1ALOX5 | |
| SCHEMBL2139326 | 0.91 | USP2 (0.47) | KDM4EUSP2THRBPTPN1ALOX5 | |
| SCHEMBL14401173 | 0.86 | USP2 (0.47) | USP2THRBPTPN1ALOX5PSMD14 | |
| SCHEMBL8846615 | 0.86 | USP2 (0.42) | USP2THRBPTPN1ALOX5PSMD14 | |
| SCHEMBL7116256 | 0.85 | USP2 (0.45) | KDM4EUSP2THRBPTPN1CYP3A4 | |
| 1,4-Butanediol SCHEMBL11042082 | 0.81 | USP2 (0.50) | KDM4EUSP2THRBCYP1A2CYP2C19 | |
| SCHEMBL272732 | 0.81 | CA1 (0.55) | USP2CYP3A4 | |
| SCHEMBL3893094 | 0.81 | USP2 (0.56) | KDM4EUSP2THRBPSMD14PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1079665-C | Personal cleansing compositions | PROCTER & GAMBLE (US) | 2002-02-27 | — | — | CN | claimed |
| US-5989536-A | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-23 | — | — | US | claimed |
| EP-0714283-B1 | PERSONAL CLEANSING COMPOSITIONS | PROCTER & GAMBLE (US) | 1999-05-12 | — | — | EP | claimed |
| CN-1130864-A | Personal cleansing compositions | PROCTER & GAMBLE (US) | 1996-09-11 | — | — | CN | claimed |
| EP-0714283-A1 | PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-05 | — | — | EP | claimed |
| WO-1995003781-A1 | PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-02-09 | — | — | WO | claimed |
| EP-1469813-B1 | ADDITIVES AND PRODUCTS INCLUDING OLIGOESTERS | CRODA INC (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-1776161-B1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | SEDERMA S A S (FR) | 2016-10-26 | — | — | EP | disclosed |
| EP-1463793-B1 | MIXTURES OF QUATERNARY COMPOUNDS | CRODA INC (US) | 2016-10-19 | — | — | EP | disclosed |
| EP-1435978-B1 | ESTERS OF AROMATIC ALKOXYLATED ALCOHOLS AND FATTY CARBOXYLIC ACIDS | CRODA INC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-8530426-B2 | Topical use of a UGT inducer-containing composition comprising a dermatologically acceptable carrier to protect and/or enhance the state of the skin/hair and prevent and/or treat imperfections of the skin; flavanoids such as chrysin stimulates isoforms; protective coatings aging/ wrinkling resistance | SEDERMA SAS (FR) | 2013-09-10 | — | — | US | disclosed |
| US-20130129656-A1 | \"GREEN\" DIESTER AMINES AND PERSONAL CARE PRODUCTS | CRODA, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-8414906-B2 | Additives and products including oligoesters | CRODA, INC. (US) | 2013-04-09 | — | — | US | disclosed |
| WO-1997001326-A1 | STABLE TOPICAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-16 | — | — | WO | disclosed |
| CN-1130864-A | Personal cleansing compositions | PROCTER & GAMBLE (US) | 1996-09-11 | — | — | CN | disclosed |
| US-5534265-A | INSOLUBILE POLYMER PARTICLES, GELLING AGENT, SURFACTANT, EMOLIENT | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-09 | — | — | US | disclosed |
| EP-0714283-A1 | PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-05 | — | — | EP | disclosed |
| WO-1996006595-A1 | PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-07 | — | — | WO | disclosed |
| WO-1995003781-A1 | PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-02-09 | — | — | WO | disclosed |
| US-4250105-A | REACTING DIHYDROXY-SUBSTITUTED ALIPHATIC COMPOUND AND CYANOGEN HALIDE | THE DOW CHEMICAL COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129656-A1 | \"GREEN\" DIESTER AMINES AND PERSONAL CARE PRODUCTS | POLR1C, TYR, QARS1 | KDM4E 2426/4885USP2 1424/4885THRB 3170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.